Similar articles

• Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia.

  Lee CA, Kernoff PB, Karayiannis P, Thomas HC. Lee CA, et al. Br J Haematol. 1989 Jun;72(2):235-8. doi: 10.1111/j.1365-2141.1989.tb07688.x. Br J Haematol. 1989. PMID: 2503026
• Alpha interferon treatment of chronic non-A, non-B hepatitis caused by intravenous gammaglobulin.

  Schvarcz R, Weiland O, Glaumann H. Schvarcz R, et al. Scand J Infect Dis. 1988;20(2):231-2. doi: 10.3109/00365548809032443. Scand J Infect Dis. 1988. PMID: 2456609
• Hazards of interferon therapy for HBV-seronegative chronic hepatitis.

  Vento S, Di Perri G, Garofano T, Cosco L, Concia E, Ferraro T, Bassetti D. Vento S, et al. Lancet. 1989 Oct 14;2(8668):926. doi: 10.1016/s0140-6736(89)91595-x. Lancet. 1989. PMID: 2571851 No abstract available.
• [Treatment of chronic hepatitis caused by C and non-A, non-B virus (NANB)].

  Trepo C, Causse X. Trepo C, et al. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):343-6. doi: 10.1016/s1140-4639(05)80041-3. Rev Fr Transfus Hemobiol. 1990. PMID: 2177595 Review. French. No abstract available.
• Treatment of chronic type C hepatitis with alpha interferon.

  Hoofnagle JH, Di Bisceglie AM. Hoofnagle JH, et al. Semin Liver Dis. 1989 Nov;9(4):259-63. doi: 10.1055/s-2008-1040520. Semin Liver Dis. 1989. PMID: 2513647 Review. No abstract available.